tiprankstipranks
Dogwood Therapeutics (DWTX)
NASDAQ:DWTX
US Market
DWTX
Dogwood Therapeutics
RESEARCH TOOLSreports

Dogwood Therapeutics (DWTX) Income Statement

259 Followers

Dogwood Therapeutics Income Statement

Last quarter (Q4 2025), Dogwood Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Dogwood Therapeutics's net income was $-3.78M. See Dogwood Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Mar 25Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -12.18K$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 27.97M$ 12.23M$ 5.45M$ 12.32M$ 15.64M
Depreciation and Amortization
$ 2.06K$ 12.18K$ 0.00$ 0.00$ 0.00
EBITDA
$ -27.97M$ -12.25M$ -5.45M$ -12.32M$ -15.64M
Operating Income
$ -27.97M$ -12.23M$ -5.45M$ -12.32M$ -15.64M
Other Income/Expenses
$ -6.07M$ -122.98K$ 150.90K$ 67.47K$ -319.33K
Pretax Income
$ -34.04M$ -12.35M$ -5.30M$ -12.25M$ -15.96M
Net Income
$ -34.26M$ -12.35M$ -5.30M$ -12.25M$ -15.96M
Per Share Metrics
Basic EPS
$ -4.32$ -12.52$ -7.05$ -27.66$ -47.90
Diluted EPS
$ -4.32$ -12.52$ -7.05$ -27.66$ -47.90
Weighted Average Shares Outstanding
 8.22M 1.03M 751.07K 442.80K 333.17K
Weighted Average Shares Outstanding (Diluted)
 8.22M 1.03M 751.07K 442.80K 333.17K
Currency in USD

Dogwood Therapeutics Earnings and Revenue History